Rosemary B. Langason

Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.

Christy S. John, Bertold J. Vilner, Mary E. Gulden et al. · PubMed · 1995 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +17

M<sub>1</sub>, M<sub>3</sub> and M<sub>5</sub> Muscarinic Receptors Stimulate Mitogen-Activated Protein Kinase

Diane R. Wotta, Elizabeth V. Wattenberg, Rosemary B. Langason et al. · Pharmacology · 1998 · 39 citations

Life Sciences, Neuroscience, Pharmacology +16

The vesamicol receptor ligand (+)-meta-[1251]iodobenzyltrozamicol {(+)-[125¦]-MIBT} reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: Possible implications for parkinson's disease

Simon M. N. Efange, Rosemary B. Langason, Anil B. Khare et al. · Life Sciences · 1996 · 13 citations

Life Sciences, Neuroscience, Pharmacology +17

N-(3-iodophenyl)trozamicol (IPHT) and related inhibitors of vesicular acetylcholine transport: synthesis and preliminary biological characterization

A. Khare, Rosemary B. Langason, Stanley M. Parsons et al. · Nuclear Medicine and Biology · 1999 · 12 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.

Simon M. N. Efange, Rosemary B. Langason, Anul B. Khare · PubMed · 1996 · 12 citations

Medicine, Neuroscience, Pharmacology +16